Prosecution Insights
Last updated: August 18, 2026

Examiner: HOLLAND, PAUL J

Tech Center 1600 • Art Units: 1636 1653 1656

This examiner grants 57% of resolved cases

Performance Statistics

57.3%
Allow Rate
-2.7% vs TC avg
834
Total Applications
+64.7%
Interview Lift
1093
Avg Prosecution Days
Based on 775 resolved cases, 2023–2026

Rejection Statute Breakdown

7.7%
§101 Eligibility
13.0%
§102 Novelty
42.8%
§103 Obviousness
26.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18279463 BIOREACTIVE COMPOUNDS AND METHODS OF USE THEREOF Non-Final OA The Regents of the University of California
18253718 RECONSTITUTION OF A SPLIT-HALOTAG VIA ORTHOGONAL TAG-BINDING DOMAINS Non-Final OA The Regents of the University of California
18016428 COMPOSITIONS AND METHODS FOR TREATING AN INHERITED RETINAL DISEASE Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17997877 ACE2 COMPOSITIONS AND METHODS Final Rejection The Regents of the University of California
18143492 Modulation of Gene Expression Via Transcription Factor-Chemically Induced Proximity (TF-CIP) Non-Final OA The Board of Trustees of the Leland Stanford Junior University
19071005 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF Non-Final OA Halozyme, Inc.
19071055 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF Non-Final OA Halozyme, Inc.
18548640 REDUCING HIGH MANNOSE GLYCAN PROTEIN EXPRESSION USING GUANOSINE 5'-MONOPHOSPHATE Final Rejection MERCK SHARP & DOHME LLC
18175893 ENGINEERED PROTEINS AND METHODS OF USE THEREOF Non-Final OA Pairwise Plants Services, Inc.
18014348 CLEANING COMPOSITIONS AND USES THEREOF Non-Final OA Henkel AG & Co. KGaA
17786561 CLEANING COMPOSITIONS COMPRISING DISPERSINS VIII Non-Final OA Henkel AG & Co. KGaA
17921035 CHIMERIC POLYPEPTIDES AND METHODS OF PREPARING SAME Final Rejection RAMOT AT TEL-AVIV UNIVERSITY LTD.
18021135 CELL HAVING GENE CORRECTED EX VIVO AND USE THEREOF Final Rejection IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY)
18691573 FACILITATED DELIVERY OF CONCENTRATED ANTIBODY FORMULATIONS USING HYALURONIDASE Non-Final OA Takeda Pharmaceutical Company Limited
18750693 THERAPEUTIC ACID CERAMIDASE COMPOSITIONS AND METHODS OF MAKING AND USING THEM Non-Final OA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
18275587 PROTEIN DEAMIDATING ENZYME Non-Final OA AMANO ENZYME INC.
17525433 CELL ENGINEERING USING RNAs Non-Final OA Boehringer Ingelheim International GmbH
17908007 Undenatured Type II Collagen in Animal Food and Treats Non-Final OA Lonza Greenwood LLC
17620557 PRODUCTION OF VECTORS USING PHAGE ORIGIN OF REPLICATION Final Rejection ASKBIO INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month